A 38-year-old woman from Mumbai with a 10-year history of recurrent gout attacks is started on allopurinol for urate-lowering therapy. Her serum uric acid before treatment was 9.1 mg/dL. After 4 weeks on allopurinol 300 mg daily, her serum uric acid drops to 4.5 mg/dL. However, she develops an acute gout flare 2 weeks after starting the drug. Which of the following biochemical events explains the paradoxical worsening of her gout despite successful uric acid lowering?

Explanation

## Paradoxical Gout Flare During Urate-Lowering Therapy **Key Point:** Acute gout flares can occur during the initiation of urate-lowering therapy (ULT) due to rapid mobilization of tissue urate stores and crystal shedding into joints. This is a well-recognized clinical phenomenon. ### Mechanism of Paradoxical Flare ```mermaid flowchart TD A[Chronic Hyperuricemia]:::outcome --> B[Tissue Urate Deposition] B --> C[Stable Monosodium Urate Deposits] C --> D[Start Allopurinol]:::action D --> E[Serum Uric Acid ↓↓]:::action E --> F{Osmotic Gradient}:::decision F -->|Urate mobilization| G[Crystal Shedding into Synovial Fluid]:::urgent G --> H[Acute Inflammatory Response]:::urgent H --> I[Gout Flare]:::urgent ``` ### Biochemical Basis **High-Yield:** When serum uric acid is rapidly lowered below the saturation point (~6.8 mg/dL), an osmotic gradient develops. Urate crystals that have been deposited in tissues over years become undersaturated in the new biochemical environment and dissolve, releasing monosodium urate crystals into synovial fluid. These crystals activate the NLRP3 inflammasome, triggering acute inflammation. **Clinical Pearl:** This phenomenon is so predictable that **prophylactic anti-inflammatory therapy** (colchicine, NSAIDs, or low-dose corticosteroids) is routinely started 2–4 weeks *before* initiating ULT and continued for 3–6 months to prevent flares. ### Timeline of Events in This Patient | Time Point | Serum Uric Acid | Clinical Event | Biochemical State | |-----------|-----------------|----------------|-------------------| | Baseline | 9.1 mg/dL | Chronic gout | Tissue deposits stable | | Week 2–4 on allopurinol | 4.5 mg/dL | Acute flare develops | Crystal mobilization begins | | Week 8–12 | 4.5 mg/dL (stable) | Flare resolves | Deposits cleared, no more shedding | **Mnemonic:** **FLARE-UP** = Fast Lowering Activates Recrystallization Events — Urate Precipitation. ### Why Allopurinol Works Allopurinol inhibits **xanthine oxidase**, the enzyme that catalyzes the final two steps of purine catabolism: - Hypoxanthine → Xanthine → Uric Acid By blocking this enzyme, allopurinol reduces uric acid production and allows serum levels to fall, but the rapid drop causes the paradoxical flare. [cite:Harrison 21e Ch 424; Robbins 10e Ch 26]